Effect of cycloheximide on the synthesis and processing of 5S RNA in HeLa cells. 1977

Y Hayashi, and R Kominami, and M Muramatsu

The synthesis and incorporation into ribosomes of 5S RNA were investigated under conditions of protein synthesis inhibition by cycloheximide. Within 1 h after addition of cycloheximide to the culture medium, the synthesis of 5S RNA in HeLa cells, as measured by the pulse labeling of total 5S RNA, was inhibited by 25-30 per cent, but the degree of inhibition did not further increase for several hours. The synthesis of 4S RNA was less markedly inhibited, especially at earlier time periods. Although the appearance of labeled 5S RNA in cytoplasmic ribosomoes after chase was inhibited by approximately 60% or more this presumably reflects the inhibition of 60S ribosomal subunit formation by cycloheximide. Some utilization of preformed 5S RNA for new ribosomes was suggested after resumption of protein synthesis. In confirmation of the results of Kumar and Wu (1), a low dose of actinomycin D inhibited the appearance of 28S RNA in the cytoplasm rather specifically, whereas cycloheximide showed an apparently opposite differential effect.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D012270 Ribosomes Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION. Ribosome
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine

Related Publications

Y Hayashi, and R Kominami, and M Muramatsu
May 1971, Science (New York, N.Y.),
Y Hayashi, and R Kominami, and M Muramatsu
September 1970, Biochemical and biophysical research communications,
Y Hayashi, and R Kominami, and M Muramatsu
May 1963, Biochemical and biophysical research communications,
Y Hayashi, and R Kominami, and M Muramatsu
July 1977, Biochemistry,
Y Hayashi, and R Kominami, and M Muramatsu
January 1986, Journal of virology,
Y Hayashi, and R Kominami, and M Muramatsu
January 1969, Radiobiologiia,
Y Hayashi, and R Kominami, and M Muramatsu
October 1970, Journal of molecular biology,
Y Hayashi, and R Kominami, and M Muramatsu
May 1970, Biochimica et biophysica acta,
Y Hayashi, and R Kominami, and M Muramatsu
June 1977, Chromosoma,
Copied contents to your clipboard!